Findings are reported from a nationwide survey of a cross-section probability sample (N = 2,552) of US adults. Data on psychic distress were obtained from a shortened version of the Hopkins symptom checklist, data on life crises from a shortened version of the Holmes-Rahe social readjustment rating scale. Methods for collecting data on use of psychotherapeutic medications were validated in a separate study. Data are presented on the prevalence of high levels of psychic distress and life crisis among various age, sex, and other demographic subgroups; on the relation between life crisis and psychic distress; and on the relation of life crisis and psychic distress to use of psychotherapeutic medications and alcohol. The findings suggest an illness behavior model for the use of psychotherapeutic medications in outpatient practice, and the lend little support to a "self-indulgent consumer" interpretation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/archpsyc.1978.01770330019001 | DOI Listing |
Cien Saude Colet
December 2024
Instituto de Saúde Coletiva, Universidade Federal da Bahia (UFBA). R. Basílio da Gama s/n, Canela. 40110-040 Salvador BA Brasil.
This work presents concepts and practices linked to mental health in the Tupinambá Indigenous community of Serra do Padeiro in southern Bahia, Brazil. This qualitative cartographic research mapped existing processes and relationships in the Tupinambá territory. Data production techniques were participant observation, semi-structured interviews, field diary, and bibliographic studies.
View Article and Find Full Text PDFBrain Sci
December 2024
Unit of Psychiatry and Eating Disorders, Department of Medicine (DMED), University of Udine, 33100 Udine, Italy.
To date, no psychotropic medication has shown to effectively halt progression to psychosis among individuals at Clinical High-Risk for psychosis (CHR), fueling the search for novel therapeutic agents. Recent evidence supports Palmitoylethanolamide (PEA) signaling as a potential psychosis biomarker, also indicating a therapeutic role for its supplementation in the treatment of psychotic disorders. Nonetheless, the effect of sustained PEA intake in CHR subjects has never been explored so far.
View Article and Find Full Text PDFJ Clin Med
November 2024
Department of Psychiatry, Faculty of Medicine, Sakarya University, 54290 Sakarya, Türkiye.
We aimed to examine the relationship of Dopamine transporter (DAT) and vesicular monoamine transporter (VMAT-2) gene and protein levels with psychic experiences and other clinical parameters in individuals with Methamphetamine Use Disorder (MUD). This study included 50 males diagnosed with MUD and 50 males as a smoking control (SC) and nonsmoking control (NSC). Community Assessment of Psychic Experiences (CAPE) was administered to patients and controls; Addiction Profile Index, Treatment Motivation Questionnaire, and Substance Craving Scale were administered only to the patient group.
View Article and Find Full Text PDFEarly Interv Psychiatry
January 2025
School of Psychology, Centre for Studies of Psychological Applications, Guangdong Key Laboratory of Mental Health and Cognitive Science, Ministry of Education Key Laboratory of Brain Cognition and Educational Science, Guangdong Emergency Response Technology Research Center for Psychological Assistance in Emergencies, South China Normal University, Guangzhou, China.
Background: Nightmares may lead to psychotic-like experiences (PLEs). The present study aimed to examine the potential moderating and mediating effects of mental health literacy (MHL) on the association between nightmare distress (ND) and PLEs among Chinese college students.
Methods: A total of 4000 college students who have had nightmares in the past year were assessed using the Chinese version of the nightmare distress questionnaire (NDQ-CV), mental health knowledge questionnaire (MHKQ), 15-item positive subscale of the community assessment of psychic experiences (CAPE-P15), 2-item insomnia questionnaire, 2-item patient health questionnaire (PHQ-2), and a self-compiled sample characteristics questionnaire.
Front Psychiatry
October 2024
Unit of Psychiatry, Department of Medicine (DMED), University of Udine, Udine, Italy.
Despite promise of its supplementation as both monotherapy and add-on treatment in autism spectrum disorder (ASD), the biobehavioral effects of Palmitoylethanolamide (PEA) in autistic adults have never been explored so far. We discussed the cases of two autistic adults with different degrees of severity (level 1 and level 2) presenting with symptoms of psychic distress, who were treated with ultramicronized-PEA (um-PEA) 600 mg/day monotherapy for a sustained period of 4 months. The level 1 autistic patient showed improved depressive symptoms and social engagement at a 12-week follow-up, in parallel to a tendency toward reduced inflammatory response and enhanced endocannabinoid (eCB) signaling, partially relapsing after um-PEA discontinuation at four months.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!